Phenomex Inc (CELL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELL | AMGN | VRTX | REGN | GILD |
| Company | Phenomex Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.9971 | 311.03 | 472.14 | 1,027.47 | 66.62 |
| High | 0.9995 | 313.41 | 476.57 | 1,040.05 | 66.93 |
| Low | 0.9970 | 308.57 | 471.76 | 1,025.80 | 66.01 |
| Last | 0.9981 | 310.88 | 474.48 | 1,034.23 | 66.69 |
| Change | +0.0031 | +1.50 | +4.20 | +10.14 | +0.10 |
| % Change | +0.31% | +0.48% | +0.89% | +0.99% | +0.15% |
| Volume | 203,900 | 1,189,412 | 778,665 | 411,324 | 4,096,329 |
| 20-Day Average Volume | 773,645 | 2,362,856 | 1,241,848 | 479,396 | 9,095,741 |
| Previous Close | 0.9950 | 309.38 | 470.28 | 1,024.09 | 66.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9877 | 308.01 | 475.19 | 1,037.74 | 66.78 |
| 20-Day Raw Stochastic | 96.45% | 50.55% | 48.50% | 47.23% | 42.18% |
| 20-Day Relative Strength | 67.01% | 55.72% | 60.08% | 56.49% | 49.00% |
| Weighted Alpha | -73.82 | +36.42 | +42.01 | +45.31 | -13.52 |
| Today's Opinion | 24% Buy | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Previous Opinion | 24% Buy | 100% Buy | 88% Buy | 80% Buy | 56% Sell |
| Last Month's Opinion | 8% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 09/22/23 | -0.90% since 06/27/24 | +0.42% since 06/27/24 | -1.58% since 06/27/24 | -3.11% since 06/27/24 |
| Low | 0.9902 on 09/25/23 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 0.9995 on 09/29/23 | 319.00 on 07/01/24 | 478.96 on 07/01/24 | 1,069.69 on 07/01/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | +5.15% since 08/29/23 | +1.14% since 06/05/24 | -1.77% since 06/05/24 | +2.82% since 06/05/24 | +4.40% since 06/05/24 |
| Low | 0.9400 on 08/31/23 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 992.22 on 06/10/24 | 62.69 on 06/18/24 |
| High | 0.9995 on 09/29/23 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | +99.62% since 06/29/23 | +15.16% since 04/05/24 | +16.67% since 04/05/24 | +9.71% since 04/05/24 | -4.15% since 04/05/24 |
| Low | 0.3801 on 08/16/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 0.9995 on 09/29/23 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | -4.03% since 03/29/23 | +2.60% since 01/05/24 | +13.92% since 01/05/24 | +13.26% since 01/05/24 | -19.95% since 01/05/24 |
| Low | 0.3801 on 08/16/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.2685 on 04/21/23 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 99,108 | 165,962,256 | 121,357,168 | 112,840,368 | 82,961,352 |
| Shares Outstanding, K | 99,297 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 78,600,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -98,040,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 14,060,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -50,250,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.95 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 08/14/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 11/14/23 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.68 | 31.46 | 28.15 | 16.97 |